Recent News
Analyst coverage tightened in December with an upgrade to a stronger rating from Stephens on December 13th, 2025, reflecting higher analyst conviction. The stock received attention for improved strength metrics and momentum in late November 2025 following renewed investor interest. The company appeared at the J.P. Morgan Healthcare Conference in mid-January 2026, maintaining visibility with institutional investors.
Technical Analysis
Directional indicators show an emerging trend: ADX at 20.36 sits just above the threshold for trend emergence while DI+ stands at 24.41 and trends higher, and DI- sits at 15.48 and trends lower; that configuration signals bullish directional momentum and supports the near-term upside narrative.
MACD reads 0.42 with the MACD line above the signal line at 0.41 and the MACD_trend increasing; the recent cross above the signal line constitutes a bullish momentum confirmation that aligns with the expectancy of continued short-term strength.
MRO registers -10.65 with a dip-and-reversal pattern; the negative MRO indicates the current price sits below the model target and implies upward pressure toward that target in the near term, reinforcing the momentum signal from MACD and directional indicators.
RSI at 58.32 with an increasing trend indicates constructive but not overbought internals; combined with price above the 12- and 26-day EMAs, the reading favors additional upside without immediate exhaustion.
Price sits above short- and long-term averages (price close $35.66 vs. 20-day avg $34.42, 50-day avg $33.74, 200-day avg $30.59) and above the 12-day EMA, a configuration that biases short-term price action higher relative to the current WMDST fair valuation.
Bollinger placement shows the close near the 1x upper band while volume (1,083,601) runs below its 10-, 50- and 200-day averages; price strength on lower-than-average volume suggests momentum requires higher participation to sustain a strong breakout.
Fundamental Analysis
Revenue and earnings dynamics show mixed signals. Quarterly and annual growth metrics read sharply negative on the provided QoQ and YoY measures: revenue growth QoQ -78.56% and revenue growth YoY -68.05%, while reported total revenue equals $1,435,016,000. EPS came in at $0.32 versus an estimate of $0.34, an EPS surprise of -5.88% (EPS difference -$0.02), indicating a small shortfall relative to consensus expectations.
Profitability margins hold modestly positive levels: EBIT margin at 5.79% slightly exceeds the industry peer mean of 5.51% and sits well above the industry peer median of 1.20%; operating margin equals 5.89% but shows year-over-year compression of -12.34% and QoQ decline of -1.55%, suggesting margin pressure despite current positive absolute levels.
Cash generation stands as a relative strength: free cash flow totals $130,242,000 with a free cash flow yield of 2.87%, which sits above the industry peer mean free cash flow yield of 1.52%, and operating cash flow equals $139,437,000; cash and short-term investments total $309,822,000, supporting liquidity.
Balance-sheet leverage and coverage warrant attention. Total debt equals $1,276,205,000 with net debt $852,014,000 and debt-to-EBITDA of 12.74, while interest coverage stands at 5.88x; the leverage ratio and elevated debt-to-EBITDA point to meaningful indebtedness relative to EBITDA that could influence capital allocation flexibility.
Return metrics show modest returns on capital: return on equity at 3.81% exceeds the industry peer mean of 1.43%, and return on assets sits at 1.51%, indicating profitable deployment of capital but at modest absolute levels. Asset turnover equals 0.42, slightly above the industry peer mean of 0.33, supporting revenue generation from invested assets.
Valuation context: price multiples appear extended on forward measures—forward P/E around 92.10 and trailing P/E about 62.94—while price-to-book registers 3.34 versus an industry peer mean of 3.64. WMDST values the stock as fair-valued; that assessment balances above-peer cash generation and margin resiliency against elevated forward multiples and notable leverage.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-09-30 |
| REPORT DATE: | 2025-10-30 |
| NEXT REPORT DATE: | 2026-01-29 |
| CASH FLOW | Begin Period Cash Flow | $ 198.8 M |
| Operating Cash Flow | $ 139.4 M | |
| Capital Expenditures | $ -9.20 M | |
| Change In Working Capital | $ 49.0 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 111.0 M | |
| End Period Cash Flow | $ 309.8 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 1.4 B | |
| Forward Revenue | $ 519.4 M | |
| COSTS | ||
| Cost Of Revenue | $ 1.2 B | |
| Depreciation | $ 17.0 M | |
| Depreciation and Amortization | $ 17.0 M | |
| Research and Development | — | |
| Total Operating Expenses | $ 1.4 B | |
| PROFITABILITY | ||
| Gross Profit | $ 272.9 M | |
| EBITDA | $ 100.2 M | |
| EBIT | $ 83.1 M | |
| Operating Income | $ 84.5 M | |
| Interest Income | — | |
| Interest Expense | $ 14.1 M | |
| Net Interest Income | $ -14.15 M | |
| Income Before Tax | $ 69.0 M | |
| Tax Provision | $ 17.2 M | |
| Tax Rate | 24.9 % | |
| Net Income | $ 51.8 M | |
| Net Income From Continuing Operations | $ 51.8 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.34 | |
| EPS Actual | $ 0.32 | |
| EPS Difference | $ -0.02 | |
| EPS Surprise | -5.882 % | |
| Forward EPS | $ 0.47 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 3.5 B | |
| Intangible Assets | $ 1.9 B | |
| Net Tangible Assets | $ -566.43 M | |
| Total Current Assets | $ 1.3 B | |
| Cash and Short-Term Investments | $ 309.8 M | |
| Cash | $ 309.8 M | |
| Net Receivables | $ 474.5 M | |
| Inventory | $ 415.7 M | |
| Long-Term Investments | $ 45.2 M | |
| LIABILITIES | ||
| Accounts Payable | $ 627.9 M | |
| Short-Term Debt | $ 6.8 M | |
| Total Current Liabilities | $ 823.9 M | |
| Net Debt | $ 852.0 M | |
| Total Debt | $ 1.3 B | |
| Total Liabilities | $ 2.1 B | |
| EQUITY | ||
| Total Equity | $ 1.4 B | |
| Retained Earnings | $ 818.4 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 8.49 | |
| Shares Outstanding | 160.108 M | |
| Revenue Per-Share | $ 8.96 | |
| VALUATION | Market Capitalization | $ 4.5 B |
| Enterprise Value | $ 5.5 B | |
| Enterprise Multiple | 54.922 | |
| Enterprise Multiple QoQ | -6.506 % | |
| Enterprise Multiple YoY | 17.842 % | |
| Enterprise Multiple IPRWA | high: 190.244 OPCH: 54.922 median: 48.181 mean: -1.131 low: -219.035 |
|
| EV/R | 3.833 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.561 | |
| Asset To Liability | 1.641 | |
| Debt To Capital | 0.484 | |
| Debt To Assets | 0.367 | |
| Debt To Assets QoQ | 0.969 % | |
| Debt To Assets YoY | 19202.105 % | |
| Debt To Assets IPRWA | high: 0.956 OPCH: 0.367 mean: 0.322 median: 0.309 low: 0.0 |
|
| Debt To Equity | 0.939 | |
| Debt To Equity QoQ | 3.965 % | |
| Debt To Equity YoY | 20453.829 % | |
| Debt To Equity IPRWA | high: 2.466 mean: 1.047 OPCH: 0.939 median: 0.879 low: -1.645 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 3.338 | |
| Price To Book QoQ | -6.603 % | |
| Price To Book YoY | -8.275 % | |
| Price To Book IPRWA | high: 27.592 mean: 3.642 OPCH: 3.338 median: 1.785 low: -9.335 |
|
| Price To Earnings (P/E) | 62.939 | |
| Price To Earnings QoQ | -17.24 % | |
| Price To Earnings YoY | -36.031 % | |
| Price To Earnings IPRWA | high: 517.132 mean: 79.241 median: 64.535 OPCH: 62.939 low: -80.57 |
|
| PE/G Ratio | 6.451 | |
| Price To Sales (P/S) | 3.16 | |
| Price To Sales QoQ | -7.923 % | |
| Price To Sales YoY | -22.148 % | |
| Price To Sales IPRWA | high: 28.774 mean: 6.148 median: 4.136 OPCH: 3.16 low: 0.079 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 92.097 | |
| Forward PE/G | 9.44 | |
| Forward P/S | 12.986 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -0.175 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.418 | |
| Asset Turnover Ratio QoQ | -1.193 % | |
| Asset Turnover Ratio YoY | 10.825 % | |
| Asset Turnover Ratio IPRWA | high: 0.945 OPCH: 0.418 median: 0.397 mean: 0.332 low: 0.001 |
|
| Receivables Turnover | 3.003 | |
| Receivables Turnover Ratio QoQ | 1.565 % | |
| Receivables Turnover Ratio YoY | 5.368 % | |
| Receivables Turnover Ratio IPRWA | high: 10.974 mean: 4.409 OPCH: 3.003 median: 2.865 low: 0.147 |
|
| Inventory Turnover | 2.837 | |
| Inventory Turnover Ratio QoQ | -4.46 % | |
| Inventory Turnover Ratio YoY | -17.814 % | |
| Inventory Turnover Ratio IPRWA | high: 6.787 median: 4.872 mean: 4.463 OPCH: 2.837 low: 0.207 |
|
| Days Sales Outstanding (DSO) | 30.387 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 14.524 | |
| Cash Conversion Cycle Days QoQ | -9.719 % | |
| Cash Conversion Cycle Days YoY | 106.724 % | |
| Cash Conversion Cycle Days IPRWA | high: 132.972 OPCH: 14.524 median: 12.463 mean: 11.449 low: -85.326 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 3.127 | |
| CapEx To Revenue | -0.006 | |
| CapEx To Depreciation | -0.539 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 2.5 B | |
| Net Invested Capital | $ 2.5 B | |
| Invested Capital | $ 2.5 B | |
| Net Tangible Assets | $ -566.43 M | |
| Net Working Capital | $ 458.9 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.376 | |
| Current Ratio | 1.557 | |
| Current Ratio QoQ | 2.488 % | |
| Current Ratio YoY | -10.072 % | |
| Current Ratio IPRWA | high: 6.656 OPCH: 1.557 mean: 1.25 median: 0.832 low: 0.004 |
|
| Quick Ratio | 1.052 | |
| Quick Ratio QoQ | 5.5 % | |
| Quick Ratio YoY | -20.538 % | |
| Quick Ratio IPRWA | high: 6.866 OPCH: 1.052 mean: 1.024 median: 0.509 low: 0.013 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 12.742 | |
| Cost Of Debt | 0.848 % | |
| Interest Coverage Ratio | 5.875 | |
| Interest Coverage Ratio QoQ | 1.889 % | |
| Interest Coverage Ratio YoY | -15.562 % | |
| Interest Coverage Ratio IPRWA | high: 30.491 OPCH: 5.875 mean: 1.927 median: 1.758 low: -59.14 |
|
| Operating Cash Flow Ratio | 0.123 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 48.451 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 2.868 % | |
| Revenue Growth | 1.337 % | |
| Revenue Growth QoQ | -78.557 % | |
| Revenue Growth YoY | -68.053 % | |
| Revenue Growth IPRWA | high: 14.194 % mean: 2.906 % median: 1.992 % OPCH: 1.337 % low: -22.095 % |
|
| Earnings Growth | 9.756 % | |
| Earnings Growth QoQ | 290.24 % | |
| Earnings Growth YoY | 192.709 % | |
| Earnings Growth IPRWA | high: 131.373 % OPCH: 9.756 % mean: -6.44 % median: -11.602 % low: -234.091 % |
|
| MARGINS | ||
| Gross Margin | 19.017 % | |
| Gross Margin QoQ | 0.095 % | |
| Gross Margin YoY | -5.299 % | |
| Gross Margin IPRWA | high: 87.689 % mean: 28.202 % median: 25.598 % OPCH: 19.017 % low: -9.25 % |
|
| EBIT Margin | 5.792 % | |
| EBIT Margin QoQ | -1.547 % | |
| EBIT Margin YoY | -13.784 % | |
| EBIT Margin IPRWA | high: 32.526 % OPCH: 5.792 % mean: 5.509 % median: 1.203 % low: -43.522 % |
|
| Return On Sales (ROS) | 5.889 % | |
| Return On Sales QoQ | 0.822 % | |
| Return On Sales YoY | -12.34 % | |
| Return On Sales IPRWA | high: 29.872 % mean: 8.081 % OPCH: 5.889 % median: 3.555 % low: -43.781 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 130.2 M | |
| Free Cash Flow Yield | 2.872 % | |
| Free Cash Flow Yield QoQ | 71.77 % | |
| Free Cash Flow Yield YoY | -1.102 % | |
| Free Cash Flow Yield IPRWA | high: 14.006 % OPCH: 2.872 % mean: 1.516 % median: 1.231 % low: -18.788 % |
|
| Free Cash Growth | 60.322 % | |
| Free Cash Growth QoQ | -110.227 % | |
| Free Cash Growth YoY | -419.012 % | |
| Free Cash Growth IPRWA | high: 558.205 % OPCH: 60.322 % mean: -7.569 % median: -49.804 % low: -423.827 % |
|
| Free Cash To Net Income | 2.514 | |
| Cash Flow Margin | 7.044 % | |
| Cash Flow To Earnings | 1.951 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.51 % | |
| Return On Assets QoQ | 0.0 % | |
| Return On Assets YoY | -5.031 % | |
| Return On Assets IPRWA | high: 7.577 % OPCH: 1.51 % median: 0.355 % mean: 0.308 % low: -22.496 % |
|
| Return On Capital Employed (ROCE) | 3.129 % | |
| Return On Equity (ROE) | 0.038 | |
| Return On Equity QoQ | 2.665 % | |
| Return On Equity YoY | 1.006 % | |
| Return On Equity IPRWA | high: 0.378 OPCH: 0.038 mean: 0.014 median: 0.011 low: -0.391 |
|
| DuPont ROE | 3.812 % | |
| Return On Invested Capital (ROIC) | 2.476 % | |
| Return On Invested Capital QoQ | 0.081 % | |
| Return On Invested Capital YoY | -118.765 % | |
| Return On Invested Capital IPRWA | high: 8.725 % OPCH: 2.476 % median: 0.766 % mean: 0.584 % low: -22.633 % |
|